Dynavax Technologies (DVAX) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 25%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $0.10 per share when it actually produced earnings of $0.12, delivering a surprise of 20%.Over the last four qua ...